Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 云南贝泰妮生物科技集团股份有限公司成立于2010年，是一家集研发、生产和营销为一体，定位于皮肤健康互联网+的大健康产业集团，贝泰妮致力于打造中国皮肤健康生态，推动中国皮肤护理大健康事业的发展。 贝泰妮被认定为国家高新技术企业及国家教育部创新团队，公司研发中心开拓创新，实施产学研结合，紧密融合植物学、生物学、皮肤学等前沿力量，在挖掘云南高原植物的有效活性成分时，开创一系列专利科技，研发新一代功效性护肤品。公司旗下护肤品牌“薇诺娜”自诞生以来，运用多项专利技术，采用基于皮肤学级的温和配方，以符合美国、欧盟化妆品要求的GMPC标准进行生产，产品的有效性、安全性得到消费者及皮肤学专业人士的广泛认可。 贝泰妮自成立以来每年均实现高速增长。通过建立电商全网渠道、终端专卖店、连锁药房OTC渠道，皮肤医疗美容诊所等营销渠道，同时推出逑美APP等线上皮肤健康护理服务平台，打造贝泰妮新零售全触点系统，成功跨界实现O2O营销，成为中国皮肤健康互联网+的领先企业。 基于公司卓越的研发实力及差异化的运作模式，凭借多年皮肤护理的专业态度，以无限拥抱互联网的胸襟胆略，贝泰妮厚积薄发，专注打造皮肤健康生态的崭新未来。
Main Business 从事皮肤护理相关医疗器械产品的研发、生产及销售业务。
Legal Representative 郭振宇
Top Executives
董事长：郭振宇
董事：张梅,周薇,马骁,高绍阳,周逵
独立董事：李宁,汪鳌,姚荣辉
Top 5 Shareholder
Shareholder name Nature Holding Date
昆明诺娜科技有限公司流通A股46.08%30/09/2024
天津红杉聚业股权投资合伙企业（有限合伙）流通A股14.58%30/09/2024
厦门臻丽咨询有限公司流通A股6.54%30/09/2024
香港中央结算有限公司流通A股3.01%30/09/2024
云南哈祈生企业管理有限公司流通A股2.60%30/09/2024
Company Secretary 王龙
Solicitors 北京市君合律师事务所
Auditors 天衡会计师事务所（特殊普通合伙）
Tel No 0871-68281899;0871-68013210
Fax No 0871-68281899;?0871-68013210
Website www.botanee.com.cn
Email BTN_PR@winona.cn；ir@winona.cn
Company Address
Register: 云南省昆明市高新区科医路53号
Office: 云南省昆明市高新区科医路53号
Listing Date 25/03/2021
Shares Capital
Shares Capital: 423,600,000
Total A Share: 423,600,000
Listed A Share: 423,600,000
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.790
DPS(RMB)* ¥ 0.600
NBV Per Share(RMB)* ¥ 13.836
Market Capitalization(RMB) 23.789B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.